# Perioperative Gabapentin Use In Head And Neck Mucosal Surgery Patients

> **NCT02926573** · PHASE4 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 123 (actual)

## Conditions studied

- Head and Neck Cancer
- Acute Pain
- Postoperative Pain

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02926573
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-24
- **Primary completion:** 2017-06-21
- **Final completion:** 2017-06-21
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02926573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02926573, "Perioperative Gabapentin Use In Head And Neck Mucosal Surgery Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02926573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*